Literature DB >> 26186950

Precision Medicine and Men's Health.

Douglas A Mata1, Farhan M Katchi2, Ranjith Ramasamy3.   

Abstract

Precision medicine can greatly benefit men's health by helping to prevent, diagnose, and treat prostate cancer, benign prostatic hyperplasia, infertility, hypogonadism, and erectile dysfunction. For example, precision medicine can facilitate the selection of men at high risk for prostate cancer for targeted prostate-specific antigen screening and chemoprevention administration, as well as assist in identifying men who are resistant to medical therapy for prostatic hyperplasia, who may instead require surgery. Precision medicine-trained clinicians can also let couples know whether their specific cause of infertility should be bypassed by sperm extraction and in vitro fertilization to prevent abnormalities in their offspring. Though precision medicine's role in the management of hypogonadism has yet to be defined, it could be used to identify biomarkers associated with individual patients' responses to treatment so that appropriate therapy can be prescribed. Last, precision medicine can improve erectile dysfunction treatment by identifying genetic polymorphisms that regulate response to medical therapies and by aiding in the selection of patients for further cardiovascular disease screening.

Entities:  

Keywords:  andrology; biologic determinants of health; genetics; health screening; physiological and endocrine disorders

Mesh:

Year:  2015        PMID: 26186950      PMCID: PMC5675324          DOI: 10.1177/1557988315595693

Source DB:  PubMed          Journal:  Am J Mens Health        ISSN: 1557-9883


  54 in total

1.  Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.

Authors:  Alexander W Pastuszak; Daniel A Hyman; Naveen Yadav; Guilherme Godoy; Larry I Lipshultz; Andre B Araujo; Mohit Khera
Journal:  J Sex Med       Date:  2015-03-02       Impact factor: 3.802

2.  Prostate-cancer mortality at 11 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Stefano Ciatto; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Hans Lilja; Marco Zappa; Louis J Denis; Franz Recker; Alvaro Páez; Liisa Määttänen; Chris H Bangma; Gunnar Aus; Sigrid Carlsson; Arnauld Villers; Xavier Rebillard; Theodorus van der Kwast; Paula M Kujala; Bert G Blijenberg; Ulf-Hakan Stenman; Andreas Huber; Kimmo Taari; Matti Hakama; Sue M Moss; Harry J de Koning; Anssi Auvinen
Journal:  N Engl J Med       Date:  2012-03-15       Impact factor: 91.245

3.  Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.

Authors:  Renée de Leeuw; Lisa D Berman-Booty; Matthew J Schiewer; Stephen J Ciment; Robert B Den; Adam P Dicker; William K Kelly; Edouard J Trabulsi; Costas D Lallas; Leonard G Gomella; Karen E Knudsen
Journal:  Clin Cancer Res       Date:  2015-02-15       Impact factor: 12.531

Review 4.  Use of diagnostic testing to detect infertility.

Authors:  Kathleen Hwang; Larry I Lipshultz; Dolores J Lamb
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

Review 5.  Genomic Predictors of Outcome in Prostate Cancer.

Authors:  Peter J Boström; Anders S Bjartell; James W F Catto; Scott E Eggener; Hans Lilja; Stacy Loeb; Jack Schalken; Thorsten Schlomm; Matthew R Cooperberg
Journal:  Eur Urol       Date:  2015-04-23       Impact factor: 20.096

6.  Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism.

Authors:  Giacomo Tirabassi; Nicola Delli Muti; Giovanni Corona; Mario Maggi; Giancarlo Balercia
Journal:  J Sex Med       Date:  2014-03-04       Impact factor: 3.802

7.  Polymorphism of the G protein β3 subunit gene influences the efficacy of sildenafil in patients with pulmonary hypertension.

Authors:  Ayumi Sekine; Nobuhiro Tanabe; Toshihiko Sugiura; Ayako Shigeta; Takayuki Jujo; Rintaro Nishimura; Seiichiro Sakao; Yasunori Kasahara; Koichiro Tatsumi
Journal:  Intern Med       Date:  2014       Impact factor: 1.271

Review 8.  CAG repeat testing of androgen receptor polymorphism: is this necessary for the best clinical management of hypogonadism?

Authors:  Davide Francomano; Emanuela A Greco; Andrea Lenzi; Antonio Aversa
Journal:  J Sex Med       Date:  2013-07-11       Impact factor: 3.802

Review 9.  The genetic epidemiology of prostate cancer and its clinical implications.

Authors:  Rosalind Eeles; Chee Goh; Elena Castro; Elizabeth Bancroft; Michelle Guy; Ali Amin Al Olama; Douglas Easton; Zsofia Kote-Jarai
Journal:  Nat Rev Urol       Date:  2013-12-03       Impact factor: 14.432

Review 10.  Penile rehabilitation following prostate cancer treatment: review of current literature.

Authors:  Jonathan Clavell-Hernandez; Run Wang
Journal:  Asian J Androl       Date:  2015 Nov-Dec       Impact factor: 3.285

View more
  1 in total

1.  Engaging Men With BRCA-Related Cancer Risks: Practical Advice for BRCA Risk Management From Male Stakeholders.

Authors:  Marleah Dean; Gemme Campbell-Salome; Emily A Rauscher
Journal:  Am J Mens Health       Date:  2020 May-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.